UCLA led collaboration demonstrates potential treatment breakthrough for advanced brain cancer
Posted on June 9, 2016
Drug Discovery and Development reported June 7 on the development of a treatment for people with recurrent brain cancers including glioblastoma, the most common and aggressive form of brain cancer. Researchers at UCLA, Cleveland Clinic and UCSD successfully demonstrated that a modified virus combined with an antifungal medication can extend the lives of patients with this deadly disease. Dr. Timothy Cloughesy, lead author of the study and member of UCLA’s Jonsson Comprehensive Cancer Center and director of the UCLA neuro-oncology program, was quoted.